Distinguishing Alzheimer’s Disease Patients and Biochemical Phenotype Analysis Using a Novel Serum Profiling Platform: Potential Involvement of the VWF/ADAMTS13 Axis
- Supplementary File 1:
ZIP-Document (ZIP, 156 KiB)
Hanas, J.S.; Hocker, J.R.S.; Vannarath, C.A.; Lerner, M.R.; Blair, S.G.; Lightfoot, S.A.; Hanas, R.J.; Couch, J.R.; Hershey, L.A. Distinguishing Alzheimer’s Disease Patients and Biochemical Phenotype Analysis Using a Novel Serum Profiling Platform: Potential Involvement of the VWF/ADAMTS13 Axis. Brain Sci. 2021, 11, 583. https://doi.org/10.3390/brainsci11050583
Hanas JS, Hocker JRS, Vannarath CA, Lerner MR, Blair SG, Lightfoot SA, Hanas RJ, Couch JR, Hershey LA. Distinguishing Alzheimer’s Disease Patients and Biochemical Phenotype Analysis Using a Novel Serum Profiling Platform: Potential Involvement of the VWF/ADAMTS13 Axis. Brain Sciences. 2021; 11(5):583. https://doi.org/10.3390/brainsci11050583
Chicago/Turabian StyleHanas, Jay S., James R.S. Hocker, Christian A. Vannarath, Megan R. Lerner, Scott G. Blair, Stan A. Lightfoot, Rushie J. Hanas, James R. Couch, and Linda A. Hershey. 2021. "Distinguishing Alzheimer’s Disease Patients and Biochemical Phenotype Analysis Using a Novel Serum Profiling Platform: Potential Involvement of the VWF/ADAMTS13 Axis" Brain Sciences 11, no. 5: 583. https://doi.org/10.3390/brainsci11050583